Web Analytics
Cổ phiếu NGNE (NASDAQ) | NEUROGENE INC – Phân tích Deepscope
MARKET

Select Market Data Region

NGNE — NEUROGENE INC (Healthcare >> Biotechnology)

NGNE FAQ

What is NGNE's ROE?

NEUROGENE INC reports a Return on Equity (ROE) of -41.48%.

What is NGNE's dividend yield?

NEUROGENE INC offers a dividend yield of 0.00%.

What is NGNE's Deepscope Quality Score?

Deepscope rates NGNE's overall financial quality at 0 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NGNE?

Deepscope's AI Timing Score for NGNE is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NGNE belong to?

NEUROGENE INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-05 | FS: 2026-03-31)

NGNE

NEUROGENE INC
USD 26.49
-0.99 (-3.60%) Day Change
0.01
D/E
-41.5%
ROE
-37.5%
ROA
0.00%
Div Yield
USD 26.49
Price
-0.99 (-3.60%)
Day Change
NEWS SCORE: 88

NGNE Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 0) và Thời điểm mua ...(Sign In to See)...

0

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng 45%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 88
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 26.49
  PBV / Sector
1.74 / 4.63
  Earning Per Share -6.33
  PE / Sector
N/A / 17.43
  PEG or PE/Growth / Sector
N/A / 0.53
  Average 1M Daily Value
3.30 M
GREAT
  Average 1W Daily Value
2.20 M
GREAT
Yếu tố Kỹ thuật 28%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 43%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 449.48
  NPM Average (%) / Sector
-8,123.68 / -1,506.49
  NPM Change Average (%) / Sector
N/A / 4,940.99
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-37.48 / 30.58
  ROA Average (%) / Sector
-31.60 / -347.17
  ROA Change Average (%) / Sector
7.27 / 5,125.52
  ROE (%) / Sector
-41.48 / -3.58
  ROE Average (%) / Sector
-35.06 / 40.65
  ROE Change Average (%) / Sector
5.35 / 2,109.80
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 4.17
Chi tiết đăng ký
X
  Analyze Date 2026-06-06 09:09:04
  Symbol NGNE
  Name NEUROGENE INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 15.80 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 413.06 / 8,857.28
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 535 W 24th Street, New York, NY, United States, 10011

Phone: 855 508 3568

Website: https://www.neurogene.com

Employees: 131

Sector: Healthcare >> Biotechnology

Description: Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.

ME vs SECTOR Healthcare >> Biotechnology

NGNE (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
NGNE
NGNE
USD 26.49 (-3.60%)
+ Watch + Port Chart